EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Combined use of EMLA cream and Buzzy for peripheral intravenous cannulation in children: a randomized controlled trial

Marco Persoglia, Irene Lapucci, Egidio Barbi, Manuela Giangreco, Paola Cogo, Giada Vittori, Daniela Slama, Anna Monsutti, Alice Martin, Giorgio Cozzi

Frontiers in Pediatrics · 23.07.2026 · 14

DOI: 10.3389/fped.2026.1816908 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Pediatrics, online erschienen am 23.07.2026. Verfasst von Marco Persoglia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Preventing pain and distress during peripheral intravenous cannulation in children is essential to avoid long-term anxiety or needle phobia. This study evaluated whether combining EMLA cream with the Buzzy device is more effective than EMLA alone in reducing procedural distress and pain. Materials and methods We conducted a randomized controlled trial in two tertiary children's hospitals in Italy (March-October 2023). Children aged 4–12 years requiring intravenous cannulation were randomized to receive either EMLA alone or EMLA plus Buzzy. The primary outcome was distress, assessed by parents using the Children's Emotional Manifestation Scale (CEMS). Secondary outcomes included pain measured with the Faces Pain Scale-Revised (FPS-R) by children, parents, and healthcare operators, operator-rated distress, first-attempt success, and adverse events. Analyses followed an intention-to-treat basis.

Results

Ninety-four children (median age 8 years) were enrolled: 47 in the EMLA plus Buzzy group and 47 in the EMLA alone group. Parent-rated distress was significantly lower with EMLA plus Buzzy (median CEMS 6, IQR 5–7) than with EMLA alone (9, IQR 7–12; p = 0.001). Pain scores and first-attempt success rates were similar. No severe adverse events occurred.

Conclusion

Combining EMLA and Buzzy significantly reduced procedural distress perceived by parents without affecting pain scores.

Schlagwörter

Stichwörter der Autor:innen

catheterization peripheralchildemotional stresslidocainepain managementprilocainevibration

Autor:innen und Institutionen

  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
  • Department of Pediatrics, University Hospital of Udine, Udine, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Persoglia, M., Lapucci, I., Barbi, E., Giangreco, M., Cogo, P., Vittori, G., Slama, D., Monsutti, A., Martin, A., & Cozzi, G. (2026). Combined use of EMLA cream and Buzzy for peripheral intravenous cannulation in children: a randomized controlled trial. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1816908

Vancouver

Persoglia M, Lapucci I, Barbi E, Giangreco M, Cogo P, Vittori G, et al. Combined use of EMLA cream and Buzzy for peripheral intravenous cannulation in children: a randomized controlled trial. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1816908

BibTeX
@article{Persoglia2026,
  author = {Persoglia, Marco and Lapucci, Irene and Barbi, Egidio and Giangreco, Manuela and Cogo, Paola and Vittori, Giada and Slama, Daniela and Monsutti, Anna and Martin, Alice and Cozzi, Giorgio},
  title = {Combined use of EMLA cream and Buzzy for peripheral intravenous cannulation in children: a randomized controlled trial},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1816908}
}
Kostenlos starten →